Search

Search Constraints

You searched for: Subject Cachexia

Search Results

361. Exogenous insulin‐like growth factor 1 attenuates cisplatin‐induced muscle atrophy in mice. Issue 6 (16th July 2021)

362. Determining the contributions of protein synthesis and breakdown to muscle atrophy requires non‐steady‐state equations. Issue 6 (21st August 2021)

364. Biomarkers related to fatty acid oxidative capacity are predictive for continued weight loss in cachectic cancer patients. Issue 6 (11th October 2021)

365. Diagnosis of sarcopenia by evaluating skeletal muscle mass by adjusted bioimpedance analysis validated with dual‐energy X‐ray absorptiometry. Issue 6 (4th October 2021)

366. Prospective trial to evaluate the prognostic value of different nutritional assessment scores for survival in pancreatic ductal adenocarcinoma (NURIMAS Pancreas SURVIVAL). Issue 6 (20th September 2021)

367. Advanced oxidation protein products contribute to chronic kidney disease‐induced muscle atrophy by inducing oxidative stress via CD36/NADPH oxidase pathway. Issue 6 (2nd October 2021)

368. Human gut microbiome impacts skeletal muscle mass via gut microbial synthesis of the short‐chain fatty acid butyrate among healthy menopausal women. Issue 6 (1st September 2021)

369. Ferric carboxymaltose in patients with pulmonary arterial hypertension and iron deficiency: a long‐term study. Issue 6 (9th September 2021)

370. Association of systemic inflammation with survival in patients with cancer cachexia: results from a multicentre cohort study. Issue 6 (2nd August 2021)